DNA-protein crosslinks (DPCs) arise in biological systems as a result of exposure to a variety of chemical and physical agents, many of which are known or suspected carcinogens. The biochemical pathways for the recognition and repair of these lesions are not well understood in part because of methodological difficulties in creating site-specific DPCs. Here, a strategy for obtaining site-specific DPCs is presented, and in vitro interactions of the Escherichia coli nucleotide excision repair (NER) UvrABC nuclease at sites of DPCs are investigated. To create site-specific DPCs, the catalytic chemistry of the T4 pyrimidine dimer glycosylase͞apurinic͞apyrimidinic site lyase (T4-pdg) has been exploited, namely, its ability to be covalently trapped to apurinic͞apyrimidinic sites within duplex DNA under reducing conditions. Incubation of the DPCs with UvrABC proteins resulted in DNA incision at the 8th phosphate 5 and the 5th and 6th phosphates 3 to the protein-adducted site, generating as a major product of the reaction a 12-mer DNA fragment crosslinked with the protein. The incision occurred only in the presence of all three protein subunits, and no incisions were observed in the nondamaged complementary strand. The UvrABC nuclease incises DPCs with a moderate efficiency. The proper assembly and catalytic function of the NER complex on DNA containing a covalently attached 16-kDa protein suggest that the NER pathway may be involved in DPC repair and that at least some subset of DPCs can be removed by this mechanism without prior proteolytic degradation.I n cells, DNA is tightly associated with a variety of proteins that serve both to maintain the structural organization of the genetic material and to coordinate cellular processes including replication, repair, recombination, and transcription. Many endogenous compounds (e.g., metabolites of lipid peroxidation) as well as environmental agents are reactive with both DNA and proteins and thus can produce covalent linkage between these two types of macromolecules (1-13). DNA-protein crosslinks (DPCs) represent a relatively abundant form of DNA damage as evidenced by data indicating that the background level of DPCs in human white blood cells ranged from 0.5 to 4.5 per 10 7 bases (1). An age-related accumulation of DPCs has also been observed in mouse organs (2), supporting the hypothesis that oxidative mechanisms contribute to the formation of these DNA damages (2, 3). DPC levels increase dramatically upon exposure to a variety of physical or chemical agents, including UV light (4), ionizing radiation (5), -propiolactone (6), aldehydes (1, 7-9), arsenite (10), ferric nitrilotriacetate (11), chromate (12), nickel (13), and others. Chemotherapeutic agents, such as cisplatin (12,14), bisplatinum (15), and neocarcinostatin (16), have also been shown to induce DPC formation. Exposure to several DPC-inducing agents gives rise to genotoxic and carcinogenic effects, and for some agents, such as formaldehyde, their primary mutagenic effects are believed to be mediated through the ...